Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings per share (EPS) is N/A as of the fiscal period ended Tuesday, December 31, 2024.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): 0.06.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T21:03:03.082Z. Historical observations retain their original dates. Historical series through 2023-11-09.
EARNINGS PER SHARE (EPS)
N/A
EARNINGS PER SHARE (EPS) AVG TTM
-0.43
EARNINGS PER SHARE (EPS) AVG 3Y
-0.44
EARNINGS PER SHARE (EPS) AVG 5Y
-0.74
EARNINGS PER SHARE (EPS) AVG 10Y
-1.18
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Precigen, Inc.
Market Cap
$2.69B
Earnings Per Share (EPS)
N/A
TTM Avg
-0.43
3Y Avg
-0.44
5Y Avg
-0.74
Market Cap
$2.70B
Earnings Per Share (EPS)
-12.45
TTM Avg
-4.69
3Y Avg
-1.64
5Y Avg
-2.01
Market Cap
$2.71B
Earnings Per Share (EPS)
-2.40
TTM Avg
-2.12
3Y Avg
-1.52
5Y Avg
-1.52
Market Cap
$2.66B
Earnings Per Share (EPS)
1.26
TTM Avg
1.10
3Y Avg
0.11
5Y Avg
-0.77
Market Cap
$2.73B
Earnings Per Share (EPS)
0.21
TTM Avg
-0.59
3Y Avg
-0.72
5Y Avg
-0.48
Market Cap
$2.77B
Earnings Per Share (EPS)
3.86
TTM Avg
3.33
3Y Avg
1.17
5Y Avg
0.32
Market Cap
$2.61B
Earnings Per Share (EPS)
-0.03
TTM Avg
-2.54
3Y Avg
-1.31
5Y Avg
-0.70
Market Cap
$2.60B
Earnings Per Share (EPS)
-2.18
TTM Avg
-2.16
3Y Avg
-1.91
5Y Avg
-1.53
Market Cap
$2.60B
Earnings Per Share (EPS)
-0.86
TTM Avg
-2.70
3Y Avg
-2.81
5Y Avg
-3.40
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Precigen, Inc. (PGEN) | $2.69B | N/A | -0.43 | -0.44 | -0.74 |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.70B | -12.45 | -4.69 | -1.64 | -2.01 |
| MBX Biosciences, Inc. Common Stock (MBX)vs › | $2.71B | -2.40 | -2.12 | -1.52 | -1.52 |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.66B | 1.26 | 1.10 | 0.11 | -0.77 |
| AtriCure, Inc. (ATRC)vs › | $2.73B | 0.21 | -0.59 | -0.72 | -0.48 |
| TransMedics Group, Inc. (TMDX)vs › | $2.77B | 3.86 | 3.33 | 1.17 | 0.32 |
| Neogen Corporation (NEOG)vs › | $2.61B | -0.03 | -2.54 | -1.31 | -0.70 |
| NewAmsterdam Pharma Company N.V. (NAMS)vs › | $2.60B | -2.18 | -2.16 | -1.91 | -1.53 |
| Beam Therapeutics Inc. (BEAM)vs › | $2.60B | -0.86 | -2.70 | -2.81 | -3.40 |
| Privia Health Group, Inc. (PRVA)vs › | $2.56B | 0.22 | 0.15 | 0.11 | -0.17 |
Trailing EPS (TTM)
N/A
Forward EPS (Est.)
$0.17
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2024-12-31 | -0.47 |
| 2023-12-31 | -0.39 |
| 2021-12-31 | -0.47 |
| 2020-12-31 | -1.02 |
| 2019-12-31 | -1.35 |
| 2018-12-31 | -3.93 |
| 2017-12-31 | -0.98 |
| 2016-12-31 | -1.58 |
| 2015-12-31 | -0.76 |
| 2014-12-31 | -0.83 |
| 2013-12-31 | -0.95 |
| 2012-12-31 | -14.80 |
| 2011-12-31 | -15.05 |
